Nemes Rush Group’s ResMed RMD Stock Holding History

Nemes Rush Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.95K	Hold	10	–	–	﹤0.01%	790
2026 Q1	$2.25K	Hold	10	–	–	﹤0.01%	729
2025 Q4	$2.41K	Buy	+10	New	+$2.56K	﹤0.01%	708

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nemes Rush Group's RMD Position: Q2 2026 in Review

Nemes Rush Group held its ResMed (RMD) position steady in Q2 2026 at 10 shares worth $1.95K. The position accounts for ﹤0.01% of the portfolio, ranked #790.

Nemes Rush Group first reported a position in RMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.41K in Q4 2025. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Nemes Rush Group held 10 shares of ResMed worth $1.95K as of Q2 2026.
Nemes Rush Group left its ResMed share count unchanged in Q2 2026.
ResMed made up ﹤0.01% of Nemes Rush Group's portfolio in Q2 2026, its #790 holding.
Nemes Rush Group first reported a position in ResMed in Q4 2025 and has held it in 3 quarters since.
Nemes Rush Group's ResMed position peaked at $2.41K in Q4 2025.
889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Nemes Rush Group's 13F filing for Q2 2026, filed 14 Aug 2026.